GOLDLINE PHARMACEUTICAL SHARE PRICE

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company w.e.f. September 23, 2013. The Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the "Goldline" brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 8 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. The Company launched the IPO comprising a fresh issue of 27,00,000 Equity shares of Rs 10 each and raised funds of Rs 11.61 crore on 14 May 2026.

Goldline Pharmaceutical share price as on 03 Sep 2026 is Rs. 40.9. Over the past 6 months, the Goldline Pharmaceutical share price has increased by 0% and in the last one year, it has decreased by 27.95%. The 52-week low for Goldline Pharmaceutical share price was Rs. 33 and 52-week high was Rs. 60.

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company w.e.f. September 23, 2013. The Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the "Goldline" brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 8 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. The Company launched the IPO comprising a fresh issue of 27,00,000 Equity shares of Rs 10 each and raised funds of Rs 11.61 crore on 14 May 2026.

Goldline Pharmaceutical share price as on 03 Sep 2026 is Rs. 40.9. Over the past 6 months, the Goldline Pharmaceutical share price has increased by 0% and in the last one year, it has decreased by 27.95%. The 52-week low for Goldline Pharmaceutical share price was Rs. 33 and 52-week high was Rs. 60.